Tender Details

Country: USA
Summary: Notice of Intent to Sole Source F18 Piflufolastat (PYLARIFY) Doses for PET/CT for Overton Brooks VA Medical Center, Shreveport, LA
UST Ref No: 115445302
Deadline: 03 Mar 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 36C25625Q0554
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
This is a notice of the Government s intent to award a sole source, Federal Supply Schedule Delivery Order to Progenics Pharmaceuticals, Inc located at 331 Treble Cove Road, N. Billerica, MA 01862 . The justification for the sole source action is the authority at FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. Network Contracting Office 16 in support of The Veterans Integrated Service Network 16 (VISN 16), Overton Brooks VA Medical Center intends to negotiate a sole source Delivery Order with Progenics Pharmaceuticals Inc. (doing business as Lantheus Medical Imaging, Inc.) under VA NAC Federal Supply Schedule 36F79719D0170 for the supply and delivery of F-18 Pylarify (piflufolastat or 18F-DCFPyl), Unit of Issue: EA, Quantity: 200. PYLARIFY is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: 1) with suspected metastasis who are candidates for initial definitive therapy, 2) with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. The National Drug Code for F-18 Pylarify is 71258-0022-01. Progenics Pharmaceuticals Inc. (SAM UEI: YLYKVRPCTCR3) is the manufacturer of F-18 Pylarify which utilizes down-chain distribution partners for delivery to its customers. F-18 is only available for purchase through Progenics Pharmaceuticals Inc. All deliveries will be made to the Overton Brooks VA Medical Center, Nuclear Medicine Service (115) located at 510 East Stoner Avenue, Shreveport LA 71101. A single delivery order will be awarded. The period of performance of the requirement will be from April 1, 2025 through March 31, 2026. The applicable NAICS code is 325412, Pharmaceutical Preparation Manufacturing (SBA Size Standard: 1300 employees). This Notice of Intent is no...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Notice of Intent to Sole Source F18 Piflufolastat (PYLARIFY) Doses for PET/CT for Overton Brooks VA Medical Center, Shreveport, LA - USA Tender

The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Notice of Intent to Sole Source F18 Piflufolastat (PYLARIFY) Doses for PET/CT for Overton Brooks VA Medical Center, Shreveport, LA. This tender is published on USARFP under UST Ref No: 115445302 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-03.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.